Wholesale CLA（Conjugated Linoleic Acid） Softgel Supplier for Private Label & Repackaging

Frequently Asked Questions (FAQ) for B2B Buyers

Q1: What does "bulk" mean for CLA softgels, and how is this different from a finished retail product?
"Bulk" CLA softgels refers to encapsulated softgel capsules supplied in large, unlabeled packaging formats — such as bulk bags, bottles, or drums — rather than in finished, retail-ready consumer bottles with labeling and packaging inserts. The encapsulation manufacturing step is already complete; what the buyer typically still needs to handle is bottling into their own retail containers, applying their own brand labeling, and completing any market-specific regulatory labeling requirements. This sourcing model is common among private label brands, distributors, and retailers who want to bring a CLA product to market without investing in their own softgel encapsulation manufacturing line. Purecium supplies bulk CLA softgels specifically structured for this repackaging and private label use case.

Q2: What certifications should a B2B bulk CLA softgel supplier have?
For dietary supplement raw materials, buyers typically look for GMP softgel encapsulation certification, HACCP food safety protocols, and ISO 22000 food safety management certification at minimum. Given CLA's role as an isomer-specific ingredient, buyers should also expect documented isomer composition testing (verifying c9,t11 and t10,c12 content via HPLC or GC), along with oxidative stability testing given the product's susceptibility to degradation as an unsaturated fatty acid oil. Purecium's Bulk CLA Softgels are produced in a GMP-compliant, HACCP-certified facility with full isomer composition and oxidation testing documentation.

Q3: What is the difference between CLA in free fatty acid (FFA) form and triglyceride (TG) form, and how is each produced?
CLA free fatty acid (FFA) form is the direct output of the alkali isomerization process, where linoleic acid released from hydrolyzed safflower or sunflower oil is converted into its conjugated isomer forms while remaining as unbound free fatty acids, not attached to a glycerol backbone. CLA triglyceride (TG) form is produced through an additional re-esterification processing step, where the purified CLA free fatty acids are chemically re-attached to a glycerol backbone, restoring a triglyceride structure closer to how fatty acids typically occur in natural dietary fats and oils. FFA-form CLA is generally more straightforward and cost-effective to produce since it skips this additional re-esterification step, while TG-form CLA requires more processing but is sometimes preferred by formulators seeking a molecular form closer to naturally occurring dietary lipids. Purecium supplies CLA softgels in both FFA and TG forms and can advise customers on which form best matches their target formulation and cost positioning.

Q4: Does CLA form (FFA vs. TG) affect absorption, stability, or formulation behavior?
Some published comparative lipid research has examined absorption and metabolic handling differences between free fatty acid and triglyceride forms of fatty acids generally, with findings suggesting triglyceride-bound forms may be processed somewhat differently by digestive lipase enzymes compared to free fatty acids, though the CLA-specific comparative research base is less extensive than for other fatty acid ingredients such as fish oil. From a formulation standpoint, FFA-form CLA is generally slightly less viscous and may have marginally different oxidative behavior compared to TG-form CLA, which can be a practical consideration for softgel encapsulation processing and shelf-life planning. Purecium can provide comparative technical documentation on both forms to support a customer's formulation decision.

Q5: What is the manufacturing process for producing CLA, and why is alkali isomerization the standard method?
Commercial CLA production typically begins with hydrolyzing a linoleic acid-rich source oil, most commonly safflower or sunflower oil, to release free linoleic acid. This free linoleic acid then undergoes alkali isomerization, a controlled chemical process using alkaline conditions and elevated temperature to reposition the double bonds in the fatty acid chain, converting a portion of the natural cis,cis-linoleic acid into the conjugated cis,trans and trans,cis isomer forms that define CLA. Alkali isomerization is the standard industry method because it reliably produces the characteristic near-equal mixture of c9,t11 and t10,c12 isomers at commercial scale; the resulting material is then purified and standardized before further processing into FFA or TG form. Purecium's CLA is produced through this alkali isomerization process from safflower oil, with isomer ratio documentation provided per batch.

Q6: Why does isomer ratio matter when sourcing CLA, and what ratio does Purecium supply?
CLA exists as multiple positional and geometric isomers, but the c9,t11 and t10,c12 isomers are the two primarily referenced in the published research literature, with each isomer associated with somewhat different areas of research interest in the general lipid metabolism literature. Because isomer ratio can vary depending on the specific isomerization process conditions used by a manufacturer, buyers formulating body composition or sports nutrition products typically request documented isomer ratio testing rather than assuming a standard composition. Purecium's CLA is standardized to an approximately 50:50 c9,t11 to t10,c12 isomer ratio as the default specification, with isomer composition verified via HPLC or GC testing per batch, and custom ratios available upon request.

Q7: What is the typical minimum order quantity (MOQ) for bulk CLA softgels?
MOQs for bulk CLA softgels vary by supplier and depend on packaging format, softgel size, and target CLA concentration, typically supplied in bulk bags, bottles, or drums given the encapsulated nature of the product. Many B2B suppliers, including Purecium, offer tiered options ranging from smaller trial/sample quantities for product evaluation and repackaging testing, up to large-volume production-scale orders for established body composition and sports nutrition brands. Buyers are generally encouraged to request a quote specifying their intended volume, target softgel size, form (FFA/TG), and isomer ratio to receive accurate MOQ and pricing information.

Q8: What softgel shell materials are available for bulk CLA softgels, and does this affect labeling claims?
Bulk CLA softgels are most commonly encapsulated in bovine gelatin shells, though marine/fish-derived gelatin shell options are also available and are relevant for brands targeting pescatarian-labeling positioning or seeking to avoid bovine-derived materials for religious dietary compliance (Halal/Kosher) reasons. The shell material selection can directly affect what labeling claims a finished product can legally make in its target market, so this is a specification point buyers should confirm explicitly rather than assume. Purecium offers both bovine and marine gelatin shell options for its bulk CLA softgels, documented on the product specification sheet.

Q9: How is oxidation tested and controlled in bulk CLA softgels?
Like other unsaturated fatty acid oils, CLA is susceptible to oxidative degradation over time, particularly given its multiple conjugated double bonds. Oxidative stability is commonly assessed through peroxide value (PV) testing, which indicates early-stage oxidation, along with sensory evaluation for off-flavors or odors that can develop as oxidation progresses. Because encapsulation itself does not stop oxidation entirely, bulk CLA softgels benefit from antioxidant stabilization during processing and light-protected packaging and storage conditions to preserve freshness between production and end-use repackaging. Purecium tests peroxide value and other oxidative stability parameters for every batch and packages bulk softgels to help manage this risk.

Q10: What documentation does a supplement brand need when importing bulk CLA softgels for repackaging?
Typical documentation includes a Certificate of Analysis (COA) covering isomer composition and total CLA potency, oxidation parameters, heavy metal test results, a Certificate of Origin, and microbiological test reports. For the US market, compliance references to FDA dietary supplement regulations (21 CFR Part 111) may be requested; for the EU, relevant EFSA-aligned documentation may be needed. Buyers should also request Non-GMO sourcing documentation if the finished product will carry any related labeling claims. Purecium provides a full documentation package with each bulk softgel shipment to support customers' import clearance and internal quality assurance processes.

Q11: Can bulk CLA softgel size, fill volume, or isomer concentration be customized?
Yes. Softgel size, fill volume (commonly ranging from 500mg to 1000mg per softgel), and total CLA concentration can typically be customized based on a customer's target finished-product dosage and positioning. Purecium offers customizable fill volume and concentration specifications, along with FFA/TG form selection and isomer ratio options, to support private label and OEM formulation requirements.

Q12: How does bulk CLA softgel sourcing compare to sourcing raw CLA oil for in-house encapsulation?
Sourcing bulk, already-encapsulated CLA softgels eliminates the need for a buyer to operate or contract out softgel encapsulation manufacturing, significantly lowering the capital investment and technical complexity required to bring a body composition or sports nutrition product to market, at the cost of somewhat less formulation flexibility compared to sourcing raw oil for custom in-house encapsulation or blending with other actives. Raw CLA oil sourcing is generally more relevant for larger brands or contract manufacturers that already operate their own encapsulation lines and want full control over blend formulation, such as combining CLA with L-Carnitine or other body composition ingredients in a single softgel. Purecium supports both models, supplying bulk pre-encapsulated softgels for repackaging customers as well as raw CLA oil for customers with their own encapsulation capability.

Q13: What quality specifications should be requested when sourcing bulk CLA softgels from a supplier?
Buyers should typically request total CLA isomer content and specific c9,t11/t10,c12 ratio (verified via HPLC or GC assay), molecular form (FFA/TG), oxidation parameters, heavy metal test results, residual solvent results, microbiological test results, shell material specification, softgel fill weight and dimensions, and shelf-life/expiration data. Requesting a full Certificate of Analysis and, where possible, a product sample for independent isomer and potency verification prior to bulk ordering is standard due-diligence practice for this ingredient category, given the importance of isomer ratio to formulation positioning. Purecium provides complete specification sheets and COAs upon request to support customer due diligence.

Q14: Does Purecium supply bulk CLA softgels for private label body composition brands?
Yes, Purecium works directly with private label brands, contract manufacturers, and distributors to supply bulk, unlabeled CLA softgels as a semi-finished product for repackaging. This includes support for FFA/TG form selection, isomer ratio and concentration specification, shell material selection, bulk packaging configuration, and documentation tailored to the brand's target regulatory market. Purecium's role is as a bulk raw material supplier; private label brands typically handle final bottling, retail labeling, and consumer packaging through their own operations or contract packaging partners, using Purecium's bulk softgels as the core product input.

Q15: How is bulk CLA softgel shelf life and storage typically managed for B2B buyers?
Properly processed and packaged bulk CLA softgels generally maintain acceptable oxidative stability for approximately 18–24 months from the date of manufacture when stored in a cool, dark environment protected from heat, light, and oxygen exposure, all of which accelerate oxidative degradation in unsaturated fatty acid products. B2B buyers are typically advised to store bulk softgels in their original light-protected bulk packaging until repackaging, and to request specific shelf-life guidance from their supplier based on the exact concentration, form (FFA/TG), and antioxidant stabilization used in that batch. Purecium provides storage and handling recommendations, along with testing data, with each shipment to help customers maintain product freshness through their own repackaging and distribution timelines.